Jama Pitman
Corporate Officer/Principal at DECIPHERA PHARMACEUTICALS, INC.
Net worth: 964 680 $ as of 2024-04-29
Network origin in Jama Pitman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 28 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jama Pitman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Chairman Chief Executive Officer Founder Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Kansas | College/University | Doctorate Degree Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| University of London | College/University | Undergraduate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Michigan | College/University | Corporate Officer/Principal Masters Business Admin | |
| TESARO INC | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
| IGNYTA INC | Biotechnology | Director/Board Member Director/Board Member | |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
| DISC MEDICINE, INC. | Biotechnology | Director/Board Member | |
| Halda Therapeutics OpCo, Inc. | Director/Board Member | ||
| Access Industries LLC | Corporate Officer/Principal | ||
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Parke-Davis Pharmaceutical Research, Inc. | Corporate Officer/Principal | ||
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Jamanda Ltd. is an investment holding British company founded in 2016. The private company is based in Grantham, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
University of Kansas Center for Research, Inc.
 University of Kansas Center for Research, Inc. Miscellaneous Commercial ServicesCommercial Services University of Kansas Center for Research, Inc. develops and administrates sponsored university programs. The not-for-profit research foundation submits proposals for external support of research, instructional, and service projects. It also provides contract negotiation, proposal and post-award, facility construction and development, resources investment, and financial management support services. The company was founded in 1962 and is headquartered in Lawrence, KS. | Miscellaneous Commercial Services | Director/Board Member | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
Bristol-Myers Squibb World Wide Medicines Group
 Bristol-Myers Squibb World Wide Medicines Group Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb World Wide Medicines Group manufactures pharmaceutical products. The company is based in Lawrenceville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ARQULE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Colgate University | College/University | Undergraduate Degree | |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| Oncology Clinical Research & Development | Director/Board Member | ||
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| THE SUSTAINABLE NUTRITION GROUP LTD | Agricultural Commodities/Milling | Director/Board Member | |
Halda Therapeutics LLC
 Halda Therapeutics LLC Medical/Nursing ServicesHealth Services Halda Therapeutics LLC engages in the development of research-stage drugs for novel therapeutic modality. The company is headquartered New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Director/Board Member | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| University of Cape Town | College/University | Doctorate Degree | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member | |
| ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman | |
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Warner-Lambert Co. LLC | Corporate Officer/Principal | ||
| State University of New York at Buffalo | College/University | Doctorate Degree |
Statistics
International
| United States | 46 |
| United Kingdom | 3 |
| Germany | 2 |
| Australia | 2 |
| South Africa | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Process Industries | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 143 |
| Corporate Officer/Principal | 72 |
| Independent Dir/Board Member | 48 |
| Chief Executive Officer | 26 |
| Undergraduate Degree | 23 |
Most connected contacts
| Insiders | |
|---|---|
| Michael Ross | 44 |
| Liam Ratcliffe | 32 |
| Edward Benz | 29 |
| Susan Kelley | 22 |
| James Bristol | 17 |
| Matthew Sherman | 16 |
| Patricia Allen | 14 |
| Michael Taylor | 14 |
| John Martin | 13 |
| Rajesh Devraj | 12 |
| Steven Hoerter | 12 |
| Daniel Flynn | 11 |
| Tucker Kelly | 10 |
| Ron Squarer | 10 |
| Christopher J. Morl | 9 |
- Stock Market
- Insiders
- Jama Pitman
- Company connections
